The HighLife transcatheter mitral valve replacement system: A novel two-component platform.

Penteris M, Lampropoulos K

Open source

DOI
10.1016/j.carrev.2025.08.012
Published
2026 Feb
Container
Cardiovascular revascularization medicine : including molecular interventions
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.carrev.2025.08.012,
  title = {The HighLife transcatheter mitral valve replacement system: A novel two-component platform.},
  author = {Penteris M and Lampropoulos K},
  year = {2026},
  journal = {Cardiovascular revascularization medicine : including molecular interventions},
  doi = {10.1016/j.carrev.2025.08.012},
  url = {https://doi.org/10.1016/j.carrev.2025.08.012}
}

RIS

TY  - JOUR
TI  - The HighLife transcatheter mitral valve replacement system: A novel two-component platform.
AU  - Penteris M
AU  - Lampropoulos K
PY  - 2026
JO  - Cardiovascular revascularization medicine : including molecular interventions
DO  - 10.1016/j.carrev.2025.08.012
UR  - https://doi.org/10.1016/j.carrev.2025.08.012
ER  - 

APA

M, P., & K, L. (2026). The HighLife transcatheter mitral valve replacement system: A novel two-component platform.. Cardiovascular revascularization medicine : including molecular interventions. https://doi.org/10.1016/j.carrev.2025.08.012

Source records